Related Experiment Video
Updated: May 14, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
Published on: January 27, 2023
Position paper update: ipecac syrup for gastrointestinal decontamination
J Höjer1, W G Troutman, K Hoppu
1European Association of Poison Centres and Clinical Toxicologists. jonas.hojer@gic.se
Ipecac syrup is not recommended for routine use in poisoning cases due to lack of evidence and potential to interfere with other treatments. Its availability is also decreasing.
Area of Science:
- Clinical Toxicology
- Poison Control
Background:
- An update to the 1997 position paper on ipecac syrup was published in 2004.
- This paper aims to summarize the 2004 position paper and present new data.
Purpose of the Study:
- To evaluate the current evidence regarding the efficacy of ipecac syrup in managing poisoned patients.
- To provide updated recommendations on the use of ipecac syrup in clinical toxicology.
Main Methods:
- A systematic literature review was conducted for studies published from 2003 onwards.
- The review focused on clinical studies assessing the outcomes of ipecac syrup administration.
Main Results:
- A limited number of relevant articles were identified.
- No convincing clinical evidence supports ipecac syrup improving outcomes for poisoned patients.
- The availability of ipecac syrup is declining.
Conclusions:
- Routine administration of ipecac syrup should be avoided.
- Ipecac syrup may hinder the effectiveness of activated charcoal and other decontamination methods.
- Insufficient evidence exists to support or refute its use in rare, specific poisoning situations.
Related Concept Videos
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Treatment Strategies
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Hand hygiene
Hand washing...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

